A new treatment to fight an extremely aggressive type of brain tumor showed promise in a pair of experiments with a handful of patients.
The strategy is focused on treating glioblastoma, one of the deadliest types of cancer, which is only diagnosed at stage 4 and has a five-year survival rate of around 10%.
Glioblastoma forms in the brain or spinal cord and grows quickly, invading and destroying healthy tissue. It can occur at any age but most often affects older adults, especially men, according to the Mayo Clinic.
